Open Heart

JUNE 14, 2023

Background Atrial fibrillation (AF) following coronary artery bypass graft surgery (CABG) is common and results in significant increases in hospital stay and financial encumbrance. Objective Determine and use the predictors of postoperative AF (POAF) following CABG to develop a new predictive screening tool.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Atrial Fibrillation Risk Factors Aortic 52

Circulation: Heart Failure

MARCH 8, 2024

Between 2016 and 2018, 3285 MESA participants from 6 field centers underwent comprehensive speckle-tracking echocardiography with passive leg raise maneuver, Kansas City Cardiomyopathy Questionnaire, 6-minute walk test, arterial stiffness assessment, and proteomics (including NT-proBNP [N-terminal pro-B-type natriuretic peptide]).Results:Median

Heart Failure 40

Heart Failure Atherosclerosis Risk Factors Kidney Disease 40

Stroke Journal

FEBRUARY 1, 2024

Patients with atrial fibrillation had a higher risk of AIS (1.47, 1.18 - 1.84) and MACE (1.26, 1.07 - 1.49). Results:Among 10,652 ICH patients (median age [IQR]: 70 [58 - 80] years; 47.7% female; 43.2% lobar ICH), 3.3%, 3.1%, 0.5%, and 8.1%, respectively, experienced r-ICH, AIS, AMI, and MACE.

Hemorrhage 40

Hemorrhage Myocardial Infarction Atrial Fibrillation Medicare 40

Dr. Smith's ECG Blog

FEBRUARY 6, 2024

Atrial fibrillation is also a predictor of worse outcomes in this case (Alborzi). 2016, April 13). Q waves in association with RBBB are usually not seen in anterior leads unless there is pulmonary hypertension or anterior infarction. RBBB in blunt chest trauma seems to be indicative of several RV injury. Zangouri, V.,

Tachycardia 110

Tachycardia Dysrhythmia Atrial Fibrillation Bradycardia 110

BoardVitals - Cardiovascular

JANUARY 18, 2021

ACS QID 75345 In 2017, the New England Journal of Medicine published the results of the Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI) trial. Other trials that evaluated this subject were the WOEST trial (2013), Pioneer AF-PCI trial (2016), and ISAR-TRIPLE (2015). Question 2.

Bicuspid/Mitral 52

Bicuspid/Mitral Atrial Fibrillation Chest Pain Obesity 52

DAIC

JUNE 19, 2024

The pipeline of algorithms likely to clear regulatory hurdles and enter the cardiac market over the next 12-18 months include those for Pulmonary Hypertension, Cardiac Amyloidosis, Diastolic dysfunction, and Hyperkalaemia. In April 2022 BMS had received FDA approval for Camzyos, the first drug developed specifically for targeting HCM.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

Stroke Journal

FEBRUARY 1, 2024

Characteristics associated with intracranial stent utilization were male sex, history of diabetes, hypertension, or chronic kidney disease, absence of atrial fibrillation or CHF, and southern US region. Patient- and hospital-level characteristics were analyzed. women; mean age, 69.1 [SD, years; mean NIHSS score of 15.1 [SD,

Stent 40

Stent Stents Stroke Strokes 40